Over the past week, the index rose 0.72%, with the U.S. dollar underpinned by safe-haven demand as escalating tensions ...

Attributed Q4 revenue declines to supply constraints from a manufacturing partner for silicon wafers, creating a backlog of ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...

Bionano Genomics Inc. stock grades by Barron's. View BNGO fundamental and sentiment analysis powered by MarketGrader.

Bionano Genomics Inc (BNGO) reports improved gross margins and cost management amid revenue declines, with promising growth ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Bionano Genomics BNGO just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

GameStop earnings, oil above $107, and Fed rate hike fears dominate this week. Major indexes down as AI stocks face scrutiny.

Bionano Genomics, Inc. BNGO will release earnings results for its fourth quarter, after the closing bell on Monday, March 23.

Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing ...